Evaxion A/S - American Depositary Share (EVAX)
6.2300
-0.4000 (-6.03%)
NASDAQ · Last Trade: Dec 10th, 10:28 AM EST
Detailed Quote
| Previous Close | 6.630 |
|---|---|
| Open | 6.630 |
| Bid | 6.210 |
| Ask | 6.270 |
| Day's Range | 6.147 - 6.630 |
| 52 Week Range | 1.200 - 12.15 |
| Volume | 28,963 |
| Market Cap | 236.10M |
| PE Ratio (TTM) | - |
| EPS (TTM) | - |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 109,354 |
Chart
About Evaxion A/S - American Depositary Share (EVAX)
Evaxion Biotech A/S is a biotechnology company that focuses on the development of innovative immunotherapies and personalized cancer treatments using its proprietary artificial intelligence platform. The company specializes in designing and developing therapeutic vaccines that harness the body's immune system to target and destroy cancer cells. By leveraging advanced machine learning algorithms, Evaxion aims to identify optimal vaccine candidates tailored to individual patients, with the goal of providing more effective and customized treatment options for various types of cancer and infectious diseases. Read More
News & Press Releases
Via Benzinga · October 17, 2025
Looking for insights into the US markets in the middle of the day on Friday? Delve into the top gainers and losers of today's session and gain valuable market intelligence.
Via Chartmill · October 17, 2025
Traders are paying attention to the gapping stocks in Friday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · October 17, 2025
Evaxion Stock Jumps A Whopping 43% Pre-Market – Here’s What Happenedstocktwits.com
Via Stocktwits · September 25, 2025
Via Benzinga · October 30, 2025
Evaxion Appoints Helen Tayton-Martin As Chief Executivestocktwits.com
Via Stocktwits · October 27, 2025
Via Benzinga · October 17, 2025
Keep an eye on the top gainers and losers in Friday's session, as they reflect the most notable price movements.
Via Chartmill · October 17, 2025
Via Benzinga · October 15, 2025
Via Benzinga · October 7, 2025
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
Via Benzinga · September 26, 2025
Gainers PepGen (NASDAQ: PEPG) stock rose 114.3% to $5.7 during Thursday's regular session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
Gainers PepGen (NASDAQ: PEPG) shares rose 141.0% to $6.41 during Thursday's pre-market session. The market value of their outstanding shares is at $87.2 million.
Via Benzinga · September 25, 2025
COPENHAGEN, Denmark, August 11, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, will provide a business update and report its second quarter 2025 financial results on Thursday August 14, 2025, before opening of the Nasdaq CM.
By Evaxion · Via GlobeNewswire · August 11, 2025
Via Benzinga · July 14, 2025
Via Benzinga · June 25, 2025
COPENHAGEN, Denmark, May 27, 2025 - Evaxion A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business update and announces first quarter 2025 financial results.
By Evaxion Biotech · Via GlobeNewswire · May 27, 2025
NEW YORK, NY / ACCESS Newswire / May 20, 2025 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day May Micro-Cap Conference taking place Wednesday and Thursday, May 21-22, 2025. The presentation schedule is subject to change. Please visit www.sidoti.com/events for the most updated version and webinar links.
Via ACCESS Newswire · May 20, 2025
By Evaxion Biotech · Via GlobeNewswire · April 1, 2025
